Trial Profile
PHASE II STUDY OF METRONOMIC ORAL VINORELBINE IN ADVANCED BREAST CANCER.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2012
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Biomarker; Therapeutic Use
- 11 Jul 2011 New trial record